{"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"142"}],"units":"Participants"}],"groups":[{"description":"DN24-02 is an autologous cellular immunotherapy product designed to stimulate an immune response against HER2/neu. It consists of autologous peripheral blood mononuclear cells (PBMCs), including antigen presenting cells (APCs), which are activated ex vivo with a recombinant fusion protein, BA7072.","id":"BG000","title":"DN24-02"},{"description":"Subjects randomized to the control arm were treated per standard of care, which in this patient population is generally observation, as there is currently no evidence that treatment with non-cisplatin-containing chemotherapy is beneficial in the adjuvant setting for this patient population.","id":"BG001","title":"Standard of Care"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"35"},{"groupId":"BG002","value":"68"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"37"},{"groupId":"BG001","value":"37"},{"groupId":"BG002","value":"74"}],"title":">=65 years"}],"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"142"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.81","value":"65.6"},{"groupId":"BG001","spread":"10.09","value":"66.4"},{"groupId":"BG002","spread":"10.42","value":"66.0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"142"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"37"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"52"},{"groupId":"BG001","value":"53"},{"groupId":"BG002","value":"105"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"142"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"4"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"65"},{"groupId":"BG001","value":"70"},{"groupId":"BG002","value":"135"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"142"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"142"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"142"}],"units":"Participants"}],"title":"United States"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"18.3080","value":"80.770"},{"groupId":"BG001","spread":"17.9330","value":"82.115"},{"groupId":"BG002","spread":"18.0679","value":"81.448"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"141"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Baseline weight for one subject in standard of care group is missing.","title":"Body weight","unitOfMeasure":"kilograms"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"38"},{"groupId":"BG002","value":"80"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"69"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"140"}],"units":"Participants"}],"title":"ECOG 0=Fully Active; No restrictions"},{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"55"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"69"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"140"}],"units":"Participants"}],"title":"ECOG 1= Restricted Strenuous Activity"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"69"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"140"}],"units":"Participants"}],"title":"ECOG 2=Ambulatory, capable of self-care; no work"}],"description":"ECOG Performance Status is a method used to assess the functional status of a patient. The scale ranges from 0-5. 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out light or sedentary work; 2=Ambulatory, capable of all self-care but unable to carry out work activities. Up and about \\>50% of waking hour; 3=Capable of limited self-care, confined to bed or chair \\>50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5=Dead","paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Baseline ECOG data is missing for one subject in each group.","title":"Eastern Cooperative Oncology Group (ECOG) Performance Status","unitOfMeasure":"Participants"}],"populationDescription":"Intent to treat population"}